The Effect of Escitalopram on Central Serotonergic and Dopaminergic Systems in Patients with Cervical Dystonia, and Its Relationship with Clinical Treatment Effects: A Double-Blind Placebo-Controlled Trial

The Effect of Escitalopram on Central Serotonergic and Dopaminergic Systems in Patients with Cervical Dystonia, and Its Relationship with Clinical Treatment Effects: A Double-Blind Placebo-Controlled Trial

<i>Purpose:</i> The pathophysiology of cervical dystonia (CD) is thought to be related to changes in dopamine and serotonin levels in the brain. We performed a double-blind trial with escitalopram (selective serotonin reuptake inhibitor; SSRI) in patients with CD. Here, we report on chan...

Full description

Bibliographic Details
Main Authors: Evelien Zoons, Marina A.J. Tijssen, Yasmine E.M. Dreissen, Marenka Smit, Jan Booij
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Biomolecules
Subjects:
cervical dystonia
single-photon emission computed tomography (SPECT)
dopamine serotonin
escitalopram
Online Access:https://www.mdpi.com/2218-273X/10/6/880

Similar Items

Similar Items